Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-60.17	64.36	161.56
Graham Fair Price	-84.08	0.47	2.95
PEG	-1122.87	-12.94	-1.06
Price/Book	-2.77	0.74	0.76
Price/Cash Flow	-59.02	234.49	572.21
Prices/Earnings	4077.92	1325.78	-31.73
Price/Sales	6.99	5.56	5.20
Price/FCF	-59.02	234.49	572.21
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	35.35	0.17	0.13
Operating Margin	20.66	0.03	-0.03
ROA	-97.68	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-97.67
ROIC	< 0.005	< 0.005	-74.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	0.17	-73.01
Dividends QOQ	2.02	-0.68	-66.25
EBIT QOQ	-3.37	2.10	-37.84
EPS QOQ	-0.30	1.02	241.65
FCF QOQ	1.03	1.37	33.14
Revenue QOQ	0.06	-0.09	46.94
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	114.86	132.61	15.45
Days Sales Outstanding (DSO)	156.13	175.10	12.15
Inventory Turnover	0.78	0.68	-13.39
Debt/Capitalization	0.08	0.08	4.23
Quick Ratio	2.73	2.53	-7.09
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.02	8.37	4.36
Cash	1.59	1.88	18.60
Capex	< 0.005	-0.04	-4121.87
Free Cash Flow	0.01	0.03	147.62
Revenue	1.17	1.11	-5.16
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.24	3.64	-14.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-25.57	-12.92	49.48
Naive Interpretation	Member

06 - Financial Health · Bad

Rating